{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:01:02Z","timestamp":1790445662870,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","worldneurosurgery.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.wneu.2017.12.096","type":"journal-article","created":{"date-parts":[[2017,12,23]],"date-time":"2017-12-23T14:28:11Z","timestamp":1514039291000},"page":"190-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Oculoleptomeningeal Amyloidosis Secondary to the Rare Transthyretin c.381T>G (p.Ile127Met) Mutation"],"prefix":"10.1016","volume":"111","author":[{"given":"Francois","family":"Mathieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1047-9305","authenticated-orcid":false,"given":"Paul","family":"Kongkham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2017.12.096_bib1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Plante-Bordeneuve","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.wneu.2017.12.096_bib2","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1136\/jnnp.2003.029942","article-title":"Familial leptomeningeal amyloidosis with a transthyretin variant Asp18Gly representing repeated subarachnoid haemorrhages with superficial siderosis","volume":"75","author":"Jin","year":"2004","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.wneu.2017.12.096_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2006.093500","article-title":"A\u00a0novel amyloidogenic transthyretin variant, Gly53Ala, associated with intermittent headaches and ataxia","volume":"78","author":"Douglass","year":"2007","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.wneu.2017.12.096_bib4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/01.wnl.0000178983.20975.af","article-title":"Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis","volume":"65","author":"Nakamura","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2017.12.096_bib5","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1212\/WNL.47.4.988","article-title":"Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene","volume":"47","author":"Herrick","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2017.12.096_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/brain\/103.3.473","article-title":"Familial oculoleptomeningeal amyloidosis","volume":"103","author":"Goren","year":"1980","journal-title":"Brain"},{"issue":"Suppl 1","key":"10.1016\/j.wneu.2017.12.096_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/13506129.2012.682187","article-title":"Genotypic and phenotypic correlation in an Italian population of hereditary amyloidosis TTR-related (HA-TTR): clinical and neurophysiological aids to diagnosis and some reflections on misdiagnosis","volume":"19","author":"Salvi","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.wneu.2017.12.096_bib8","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/WNL.0b013e3181a0fe74","article-title":"Highly selective leptomeningeal amyloidosis with transthyretin variant Ala25Thr","volume":"72","author":"Hagiwara","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2017.12.096_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/13506120600551814","article-title":"A\u00a0case of biopsy-proven leptomeningeal amyloidosis and intravenous Ig-responsive polyneuropathy associated with the Ala25Thr transthyretin gene mutation","volume":"13","author":"Shimizu","year":"2006","journal-title":"Amyloid"},{"issue":"Suppl 1","key":"10.1016\/j.wneu.2017.12.096_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/13506129.2011.574354060","article-title":"A\u00a0new transthyretin mutation associated with leptomeningeal amyloidosis","volume":"18","author":"Liepnieks","year":"2011","journal-title":"Amyloid"},{"key":"10.1016\/j.wneu.2017.12.096_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1212\/WNL.57.1.135","article-title":"Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu)","volume":"57","author":"Ellie","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2017.12.096_bib12","first-page":"228","article-title":"Oculoleptomeningeal amyloidosis associated with transthyretin Leu12Pro in an African patient","volume":"262","author":"McColgan","year":"2015","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.wneu.2017.12.096_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3129\/i09-023","article-title":"Oculoleptomeningeal amyloidosis in 3 individuals with the transthyretin variant Tyr69His","volume":"44","author":"Schweitzer","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.wneu.2017.12.096_bib14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.humpath.2013.10.037","article-title":"The pathologic spectrum of oculoleptomeningeal amyloidosis with Val30Gly transthyretin gene mutation in a postmortem case","volume":"45","author":"Martin","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.wneu.2017.12.096_bib15","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/archneur.56.9.1152","article-title":"Oculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64","volume":"56","author":"Uemichi","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.wneu.2017.12.096_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.5692\/clinicalneurol.cn-000911","article-title":"An autopsy case of leptomeningeal amyloidosis associated with transthyretin Gly47Arg mutation","volume":"56","author":"Uehara","year":"2016","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.wneu.2017.12.096_bib17","first-page":"351","article-title":"Leptomeningeal amyloid and variant transthyretins","volume":"148","author":"Benson","year":"1996","journal-title":"Am J Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.wneu.2017.12.096_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/13506129.2012.665400","article-title":"Genotype\u2013phenotype correlation in FAP","volume":"19","author":"Zeldenrust","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.wneu.2017.12.096_bib19","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/jnnp-2014-308724","article-title":"Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments","volume":"86","author":"Sekijima","year":"2015","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.wneu.2017.12.096_bib20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/eye.2014.10","article-title":"Multimodal retinal imaging in a Chinese kindred with familial amyloid polyneuropathy secondary to transthyretin Ile107Met mutation","volume":"28","author":"Lv","year":"2014","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.wneu.2017.12.096_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5692\/clinicalneurol.cn-000852","article-title":"A\u00a0case of familial amyloid polyneuropathy (FAP ATTR Ile107Val) with proximal muscle weakness in the lower extremities","volume":"56","author":"Kuzume","year":"2016","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.wneu.2017.12.096_bib22","series-title":"Familial transthyretin amyloidosis","author":"Sekijima","year":"2012"},{"key":"10.1016\/j.wneu.2017.12.096_bib23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jns.2008.05.014","article-title":"A\u00a0new Thr49Pro transthyretin gene mutation associated with leptomeningeal amyloidosis","volume":"272","author":"Nakagawa","year":"2008","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.wneu.2017.12.096_bib24","doi-asserted-by":"crossref","first-page":"49707","DOI":"10.1074\/jbc.M306748200","article-title":"In\u00a0vitro and in\u00a0vivo interactions of homocysteine with human plasma transthyretin","volume":"278","author":"Lim","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.wneu.2017.12.096_bib25","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ana.24145","article-title":"Homocystein exacerbates b-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles","volume":"75","author":"Li","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.wneu.2017.12.096_bib26","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.wneu.2017.12.096_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40120-015-0031-3","article-title":"A\u00a0review of tafamidis for the treatment of transthyretin-related amyloidosis","volume":"4","author":"Waddington Cruz","year":"2015","journal-title":"Neurol Ther"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187887501732212X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187887501732212X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,15]],"date-time":"2018-07-15T04:38:53Z","timestamp":1531629533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187887501732212X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":27,"alternative-id":["S187887501732212X"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2017.12.096","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oculoleptomeningeal Amyloidosis Secondary to the Rare Transthyretin c.381T>G (p.Ile127Met) Mutation","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2017.12.096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}